The inhibition of cytochrome-c release is also involved in the dexamethasone-induced cardiac protection [8]; however lysosomal disruption is an important consequence of myocardial ischemia and early treatment with dexamethasone prevents the loss of myocardial lysosomal and cellular enzymes. Here, CYCS is linked to myocardial ischemia.